JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.63% |
| 2 | Financials | 11.06% |
| 3 | Consumer Discretionary | 10.11% |
| 4 | Healthcare | 9.56% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOR
4926
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $230K | ﹤0.01% |
193
+155
| +408% | +$214K |
|
4927
First Majestic Silver
AG
$9.26B
| $229K | ﹤0.01% |
14,687
-17,931
| -55% | -$287K |
|
4928
Champions Oncology
CSBR
$70.6M
| $229K | ﹤0.01% |
20,287
+1,460
| +8% | +$16.9K |
|
4929
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.65B
| $229K | ﹤0.01% |
+7,727
| New | +$225K |
|
|
PTRS
4930
DELISTED
Partners Bancorp Common Stock
PTRS
| $228K | ﹤0.01% |
31,145
+1,960
| +7% | +$13.6K |
|
4931
iShares MSCI Poland ETF
EPOL
$813M
| $227K | ﹤0.01% |
12,525
-785
| -6% | -$15K |
|
4932
Jakks Pacific
JAKK
$294M
| $227K | ﹤0.01% |
+31,900
| New | +$244K |
|
4933
NVE Corp
NVEC
$563M
| $227K | ﹤0.01% |
3,230
-23,781
| -88% | -$1.61M |
|
|
SOLY
4934
DELISTED
Soliton, Inc.
SOLY
| $227K | ﹤0.01% |
12,937
-3,751
| -22% | -$47.9K |
|
4935
Shattuck Labs
STTK
$735M
| $226K | ﹤0.01% |
7,703
-29,425
| -79% | -$1.24M |
|
|
ALBO
4936
DELISTED
Albireo Pharma Inc
ALBO
| $226K | ﹤0.01% |
6,415
-1,118
| -15% | -$41.3K |
|
|
LONA
4937
LeonaBio Inc
LONA
$73.9M
| $225K | ﹤0.01% |
1,223
-1,908
| -61% | -$421K |
|
4938
Roundhill Sports Betting & iGaming ETF
BETZ
$50M
| $224K | ﹤0.01% |
+7,287
| New | +$220K |
|
4939
abrdn Physical Silver Shares ETF
SIVR
$4.47B
| $224K | ﹤0.01% |
9,479
+1,845
| +24% | +$46.7K |
|
4940
Sabesp
SBS
$16.5B
| $223K | ﹤0.01% |
156,861
-176,261
| -53% | -$254K |
|
4941
SIGA Technologies
SIGA
$207M
| $223K | ﹤0.01% |
34,240
+1,027
| +3% | +$6.96K |
|
4942
PUT
Steel Dynamics
STLD
$37.3B
| $223K | ﹤0.01% |
4,400
-500
| -10% | -$21.1K |
|
|
SHSP
4943
DELISTED
SharpSpring, Inc.
SHSP
| $221K | ﹤0.01% |
13,797
+10,235
| +287% | +$203K |
|
4944
PUT
Opko Health
OPK
$1.04B
| $220K | ﹤0.01% |
51,300
+12,500
| +32% | +$59.7K |
|
|
PRVB
4945
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $220K | ﹤0.01% |
20,893
-1,206
| -5% | -$17K |
|
|
PVG
4946
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
| $220K | ﹤0.01% |
21,200
| – | – |
|
4947
Rigel Pharmaceuticals
RIGL
$762M
| $219K | ﹤0.01% |
6,407
-51,692
| -89% | -$2.05M |
|
4948
Talphera
TLPH
$62.8M
| $219K | ﹤0.01% |
6,426
-383
| -6% | -$15.2K |
|
4949
Galectin Therapeutics
GALT
$356M
| $218K | ﹤0.01% |
100,555
-3,158
| -3% | -$7.08K |
|
|
AWH
4950
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $218K | ﹤0.01% |
2,146
-194
| -8% | -$21.3K |
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $27.4B of net new capital in Q1 2021, opening 866 new positions and adding to 2,870 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 462 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.